Biotech and medical business blog

Visit BioHealth Investor

Roches AIDS (Retinitis) & Organ Transplant Drug Going Generic?

Posted on June 25, 2008

Roche Holdings Ltd. appears to have lost some protection on Valganciclovir HCl. The FDA has granted Ranbaxy Laboratories Ltd. tentative approval to manufacture and market Valganciclovir Hydrochloride Tablets (450 mg).Valganciclovir HCl Tablets are indicated for the treatment of cytomegalovirus (CMV) retinitis in patients with AIDS. Valganciclovir HCl is also indicated for the prevention of cytomegalovirus [...]...

Original article link